SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-304041
Filing Date
2021-10-21
Accepted
2021-10-21 16:24:05
Documents
18
Period of Report
2021-10-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d216092d8k.htm   iXBRL 8-K 31874
2 EX-1.1 d216092dex11.htm EX-1.1 207218
3 EX-5.1 d216092dex51.htm EX-5.1 13172
4 EX-99.1 d216092dex991.htm EX-99.1 10395
5 EX-99.2 d216092dex992.htm EX-99.2 10760
9 GRAPHIC g216092g1021131904852.jpg GRAPHIC 1785
10 GRAPHIC g216092g1021132401291.jpg GRAPHIC 3345
  Complete submission text file 0001193125-21-304041.txt   479325

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA crnx-20211020.xsd EX-101.SCH 2896
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20211020_lab.xml EX-101.LAB 18889
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20211020_pre.xml EX-101.PRE 11863
11 EXTRACTED XBRL INSTANCE DOCUMENT d216092d8k_htm.xml XML 3487
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 211337269
SIC: 2834 Pharmaceutical Preparations